Jul 2, 2026 07:00AM
Jun 18, 2026 07:03AM
Jun 18, 2026 07:00AM
May 18, 2026 04:46PM
May 8, 2026 08:19AM
May 8, 2026 07:00AM
Apr 14, 2026 07:02AM Kiora Pharmaceuticals publishes phase 1 retinitis pigmentosa study data
Apr 14, 2026 07:00AM
Apr 7, 2026 07:01AM
Apr 7, 2026 07:00AM
Apr 2, 2026 04:31PM
Apr 2, 2026 04:30PM
Mar 25, 2026 07:02AM
Mar 25, 2026 07:00AM Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials
Feb 19, 2026 08:30AM
Jan 27, 2026 07:03AM
Jan 27, 2026 07:00AM
Dec 1, 2025 06:47AM
Dec 1, 2025 06:45AM
Nov 7, 2025 06:49AM
Nov 7, 2025 06:02AM Kiora Pharmaceuticals posts net income in Q3 amid ongoing clinical trials
Nov 7, 2025 06:00AM
Oct 30, 2025 09:01AM
Oct 15, 2025 07:00AM
Sep 4, 2025 07:00AM
Aug 8, 2025 07:02AM
Aug 8, 2025 07:00AM
Aug 7, 2025 07:00AM Kiora Pharmaceuticals to Showcase Its Retinal Disease Therapeutic Pipeline at The H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
Jul 22, 2025 08:57AM
Jul 22, 2025 08:55AM
Jun 3, 2025 07:02AM
Jun 3, 2025 07:00AM
May 9, 2025 07:35AM
May 9, 2025 07:00AM
May 5, 2025 07:00AM Kiora Pharmaceuticals Presents In Vivo Preclinical Data at ARVO 2025 Demonstrating the Potential of KIO-104 to Treat Proliferative Vitreoretinopathy
Apr 4, 2025 07:00AM
Mar 25, 2025 07:00AM
Mar 12, 2025 07:00AM
Feb 13, 2025 07:03AM
Feb 13, 2025 07:00AM
Feb 11, 2025 06:46AM
Feb 11, 2025 06:45AM Kiora Receives Approval to Initiate KLARITY, a Phase 2 Clinical Trial of KIO-104 for the Treatment of Retinal Macular Edema
Nov 12, 2024 07:50AM
Nov 8, 2024 07:36AM
Nov 8, 2024 07:00AM
Oct 29, 2024 06:47AM
Oct 29, 2024 06:45AM
Sep 25, 2024 09:55AM
Aug 9, 2024 08:31AM Kiora Pharmaceuticals (KPRX) Misses Q2 EPS by 53c
Aug 9, 2024 07:00AM

423,234 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All